MariMed Announces Fourth Quarter 2022 Earnings Date
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a multi-state cannabis operator, announced it will release its Q4 2022 financial results on March 1, 2023, after market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
MariMed Inc. (CSE: MRMD, OTCQX: MRMD), a multi-state cannabis operator, announced it will release its Q4 2022 financial results on March 1, 2023, after market close. Following this, management will host a conference call on March 2, 2023, at 8:00 a.m. EST to discuss the results. Investors can access a webcast of the earnings call via MariMed's Investor Relations website. The company focuses on high-quality cannabis products and operates state-licensed facilities, aiming to enhance lives through its innovative offerings. For more information, visit www.marimedinc.com.
Details
News Market Reaction – MRMD
The recorded move for MRMD in the trading session of this news was +2.56%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
NORWOOD, Mass., Feb. 01, 2023 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed” or the “Company”), (CSE: MRMD), (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day, today announced it will report its fourth quarter 2022 financial results on March 1, 2023 after the markets close. Management will host a conference call on March 2, 2023 at 8:00 a.m. EST to discuss financial results.
A webcast will be available and can be accessed via MariMed’s Investor Relations website at MariMed Q422 Earnings Webcast. To listen to the live call, please visit the website at least 15 minutes prior to the call to register, download and install any necessary audio software. A playback of the call will be archived on MariMed’s website for approximately 30 days.
About MariMed
MariMed Inc., a multi-state cannabis operator, is dedicated to improving lives every day through its high-quality products, its actions, and its values. The Company develops, owns, and manages seed to sale state-licensed cannabis facilities, which are models of excellence in horticultural principles, cannabis cultivation, cannabis-infused products, and dispensary operations. MariMed has an experienced management team that has produced consistent growth and success for the Company and its managed business units. Proprietary formulations created by the Company’s technicians are embedded in its top-selling and award-winning products and brands, including Betty's Eddies, Nature’s Heritage, InHouse, Bubby’s Baked, K Fusion, Kalm Fusion, and Vibations: High + Energy. For additional information, visit www.marimedinc.com.
Investor Relations Contact:
Steve West
Vice President, Investor Relations
Email: ir@marimedinc.com
Phone: (781) 277-0007
Company Contact:
Howard Schacter
Chief Communications Officer
Email: hschacter@marimedinc.com
Phone: (781) 277-0007
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.